Dr. Sud is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 N Rose Dr
Suite 134
Placentia, CA 92870Phone+1 714-996-6500
Summary
- Bhanu Sud, MD is a specialist in Infectious Disease based in Placentia, CA. He completed his educational journey at Nehru Medical College/R. Gandhi HS University, graduating in 2000, and further honed his expertise during his Residency and Fellowship at University of Oklahoma Health Sciences Center between 2002 and 2007. Dr. Sud focuses on prevertebral infections, mandibular space infections, and transplant site infections. He has made esteemed contributions to Critical Care Medicine, The Medical Journal of Australia, and Oklahoma State Medical Association with his research centered around severe sepsis treatment, infected atrial myxoma, and various drugs such as trimethoprim-sulfamethoxazole, nitrofurantoin, among others.
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Infectious Disease, 2005 - 2007- University of Oklahoma Health Sciences CenterResidency, Internal Medicine, 2002 - 2005
Nehru Medical College/ R. Gandhi HS UniversityClass of 2000
Certifications & Licensure
CA State Medical License 2007 - 2027
OK State Medical License 2004 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 35 citationsAdverse outcomes associated with the use of drotrecogin alfa (activated) in patients with severe sepsis and baseline bleeding precautions.Chris A. Gentry, Kristin Busse Gross, Bhanu Sud, Douglas A. Drevets
Critical Care Medicine. 2009-01-01 - 4 citationsInfected atrial myxoma.Ahmed Awab, Mehdi Hamadani, Bhanu Sud, Gene W Voskuhl
The Medical Journal of Australia. 2006-09-18 - Part XI. Trimethoprim-sulfamethoxazole, nitrofurantoin, chloramphenicol, metronidazole and tinidazole, rifaximin, and nitazoxanideBhanu Sud, Michelle R Salvaggio, Ronald A. Greenfield, Michael S. Bronze
The Journal of the Oklahoma State Medical Association. 2007-07-01
Press Mentions
The Latest on the Coronavirus: Rand Paul First Senator to Contract COVID-19March 21st, 2020
It’s Supposed to Be a ‘Mild’ Year in Orange County for West Nile Virus, but You Should Still Take PrecautionsJuly 18th, 2018
Other Languages
- Hindi, Urdu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
